Observational follow-up study of patients included in the clinical trial REGATTA.
A follow-up telephone interview of the participants of the clinical trial REGATTA exploring the occurrence of urinary tract infections, pyelonephritis within a follow-up period of three months after inclusion.
Study Type
OBSERVATIONAL
Enrollment
398
application of a herbal drug in the clinical trial REGATTA (NCT03151603)
application of Placebo to Fosfomycin in the clinical trial REGATTA (NCT03151603)
application of an antibiotic drug in the clinical trial REGATTA (NCT03151603)
number of urinary tract infections
number of urinary tract infection within 3 months after inclusion in REGATTA
Time frame: 3 months after inclusion in REGATTA
number of pyelonephritis
number of pyelonephritis within 3 months after inclusion in REGATTA
Time frame: 3 months after inclusion in REGATTA
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
application of Placebo to Arctuvan in the clinical trial REGATTA (NCT03151603)
Hausarztpraxis Dr. Raby
Achim, Germany
General Practice Aden
Braunschweig, Germany
General Practice Scheffer
Braunschweig, Germany
General Practice Coutelle
Bremen, Germany
General Practice Schelp
Bremen, Germany
General Practice Dickow
Burgwedel, Germany
General Practice Kiwit-Putzer
Burgwedel, Germany
Praxis Zietz
Celle, Germany
General Practice Kutzsche
Emmerthal, Germany
Praxis Dr. Bahr
Gieboldehausen, Germany
...and 37 more locations